Dark

RGC
Regencell Bioscience Holdings Limited
stock NASDAQ

At Close

Jan 30, 2026 3:59:30 PM EST

24.76USD-11.239%(-3.14)289,392

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jan 30, 2026 8:46:30 AM EST

27.21USD-2.456%(-0.69)233

After-hours

Jan 30, 2026 4:42:30 PM EST

25.01USD+1.010%(+0.25)442

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

12.36B

Headquarters

TN, USA

Industry

Drug Manufacturers-Specialty & Generic

Next Earnings

Jun 2, 2026 (120d)

Last Split

Jun 16, 202538for1

RDI MCS CNK AMC

RGC Stats

Avg. Vol. 10 Day

548,782

Avg. Vol. 30 Day

784,977

Employees

26,000

Market Cap

12,362,173,251

Shares Out.

494,488,908

On/Off Exchange

53%/47%

6 Month Beta

2.53

1 Year Beta

-0.19

2 Year Beta

0.10

3 Year Beta

0.08

52 Week Low

0.09

52 Week High

83.60

SMA50

22.89

SMA200

16.76

1 Week

-20.41%

1 Month

+19.05%

3 Month

+50.15%

6 Month

+89.39%

1 Year

+24,899.90%

2 Year

+11,907.64%

5 Year

+8,948.10%

Profile

we are an early-stage bioscience company that focuses on research, development and commercialization of tcm for the treatment of neurocognitive disorders and degeneration, specifically attention deficit hyperactivity disorder ("adhd"), autism spectrum disorder ("asd") in infectious diseases such as covid-19. our goal is to improve the lives of adhd, asd and covid patients, their families and caregivers and become a market leader for the best tcm treatment globally.

RGC Stock Summary

Regencell Bioscience Holdings Limited (NASDAQ:RGC) stock price today is $24.76, and today's volume is 289,392. RGC is down -11.239% today. The 30 day average volume is 784,977. RGC market cap is 12.36B with 494,488,908 shares outstanding.